LNTH READ THE FULL LNTH RESEARCH REPORT As 2026 begins, we are updating investors on Lantheus Holdings, Inc. (NASDAQ:LNTH), ...

Holdings completed the previously announced sale of its single photon emission computed tomography business to SHINE Technologies. Under the terms of the agreement, SHINE has acquired Lantheus’ SPECT ...

Bone SPECT/CT imaging – the integration of functional single photon emission computed tomography with anatomical computed tomography – represents a significant advancement in the evaluation of foot ...

SHINE acquires Billerica manufacturing facility and established SPECT product portfolio, expanding leadership in nuclear medicine JANESVILLE, Wis., Jan. 2, 2026 /PRNewswire/ -- SHINE announced today ...

Cornell University and The General Hospital Corp. (Massachusetts General Hospital) have synthesized conjugates comprising a targeting moiety covalently linked to a radiolabeled metal chelator through ...

BEDFORD, Mass., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians ...

SHINE acquires Billerica manufacturing facility and established SPECT product portfolio, expanding leadership in nuclear ...

BEDFORD, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc., the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver ...

With the SPECT divestiture finalized, Lantheus will focus on its growing commercial portfolio of innovative PET radiodiagnostics and microbubbles, while also advancing its pipeline of ...